The Clinical Times
The Front Page of Medicine

Drugs & FDA · page 11

Drug approvals, label changes, and FDA drug news.

FDA Drugs · Jun 18, 2026

Commissioner's National Priority Voucher (CNPV) Pilot Program

FDA Commissioner's National Priority Voucher Program. The Commissioner's National Priority Voucher Program offers an unprecedented opportunity to reduce drug and biologic review times from 10-12 months to just 1-2 months.

FDA Drugs · Jun 18, 2026

¿Deben medicarse las encías de los bebés durante la dentición? No

La dentición es una fase normal de la infancia que no necesita “curarse” con medicamentos recetados o de venta libre. La FDA advierte a los padres que los productos que contienen benzocaína no son seguros para tratar la dentición en los niños. Hay alternativas no tóxicas más seguras.

FDA Drugs · Jun 18, 2026

Lessons Learned from our Roundtable with Rare Disease Advocates

Recently FDA leadership held a roundtable discussion with 15 dedicated rare disease leaders. Hearing directly from patients and family members who navigate these incredibly challenging conditions every day was both grounding and motivating.

FDA Newsroom · Jun 17, 2026

FDA Approves First Single-Dose Generic Treatment for Influenza

The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.

FDA Drugs · Jun 17, 2026

Notices of Updates

Webpage providing notices of updates to FDA's STIC webpages for antibacterial and antifungal drugs.

← Newer

Back to the live front page